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The specific mechanism by which the inhibitory guanine nucleotide binding protein (G,) mediates the inhibition of adenylate cyclase activity is 
still unclear. The subunit dissociation model, based on studies in purified or reconstituted systems, suggests that the j?y subunit, which is dissociated 
with activation of Gi, inhibits the function of the stimulatory guanine nucleotide binding protein (G$) by reducing the concentration of the free 
CL, subunit. In the present study, G, protein function is determined by measuring cholera toxin-blockable, isoproterenol-induced increases in guano- 
sine triphosphate (GTP) binding capacity to rat cardiac ventricle membrane preparations. Carbamylcholine totally inhibited this /?-adrenergic recep- 
tor-coupled G, protein function. Pretreatment of the cardiac ventricle membrane preparation with pertussis toxin prevented this muscarinic agonist 
effect. These results confirm the possibility of an inhibitory agonist-receptor coupled effect hrough Gi on G, protein function proximal to the catalyt- 
ic unit of adenylate cyclase in an intact membrane preparation. 
G protein; Adenylate cyclase; I-Adrenergic receptor; Muscarinic receptor 
1. INTRODUCTION 
Adenylate cyclase activity is dually regulated by 
membrane receptors that activate specific guanine 
nucleotide binding proteins. Stimulatory receptors (e.g. 
,8-adrenergic receptors) activate a specific adenylate 
cyclase-stimulatory G protein (GJ while inhibitory 
receptors (e.g. muscarinic recptors) activate an in- 
hibitory guanine nucleotide binding protein (Gi) (for 
review, see [l]). 
The mechanism of adenylate cyclase activation by G, 
is well understood. Specifically, hormones or neuro- 
transmitters interact with their specific receptors to 
stimulate the binding of guanosine triphosphate (GTP) 
to the LY subunit of G,, which is concomitantly followed 
by subunit dissociation. Thus formed, the GTP-bound 
cys directly activates adenylate cyclase [1,2]. 
The specific mechanism by which Gi mediates the in- 
hibition of adenylate cyclase activity is still unclear and 
controversial. The subunit dissociation model [1,3,4] 
proposes that the ,8y subunit, which is dissociated with 
activation of Gi, indirectly inhibits adenylate cyclase by 
reducing the concentration of the free a, subunit. The 
resulting association of fly and ays forms an inactive 
trimer of G,. Two additional models propose direct in- 
hibition of adenylate cyclase by either the activated ai 
[5-71 or fly subunits [8]. All the above models are bas- 
ed on experiments carried out mostly on purified or 
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reconstituted components of the receptor-G protein- 
adenylate cyclase complexes. 
An important characteristic of G proteins is their in- 
creased guanine nucleotide binding following agonist 
stimulation which in turn leads to their activation. 
Although basal binding of guanine nucleotides to cer- 
tain crude membrane preparations is not exclusive to G 
proteins [9], there is no dispute that agonist-induced in- 
creases in guanine nucleotide binding are an exclusive 
characteristic of G proteins and may serve to assess 
receptor-coupled G protein function proximal to 
adenylate cyclase [ 10,111. 
In the present study, G, protein function was deter- 
mined by measuring cholera toxin-blockable, 
,&adrenergic agonist-induced increases in [3H]GTP 
binding to membrane preparations from rat cardiac 
ventricles to test the possibility of an inhibitory agonist- 
receptor coupled effect through Gi on G, protein func- 
tion proximal to adenylate cyclase. 
2. MATERIALS AND METHODS 
2.1. Cardiac ventricle membrane preparation 
Male Sprague-Dawley rats (200-250 g) were decapitated, and the 
cardiac ventricles were rapidly removed and homogenized in buffer 
A (25 mM Tris, pH 7.4, 1 mM dithiothreitol (DTT)) containing 
1 mM ethyleneglycol-bis-(&aminoethylether)-N (EGTA). Cardiac 
ventricle homogenate was then passed through double-layer cheese- 
cloth. Membranes were obtained by centrifuging the preparations 
twice for 10 min at 10000 x g and 4°C. 
2.2. rHJGTP binding to r@t cardiac ventricle membranes 
2004 of membranes (0.5-1.5 mg protein) suspended in 25 mM 
Tris (pH 7.4), 1 mM adenosine triphosphate (ATP), 2.2 mM Mg’+, 
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1 mM EGTA, and 1 mM DTT, were pipetted into plastic microfuge 
tubes containing varying concentrations of [3H]GTP (0.04-0.6 PM). 
The incubation was carried out at room temperature for 5 min 
(equilibrium conditions) and the reaction was stopped by adding 
5 vols of ice-cold buffer A, followed by centrifugation at 10~ x g 
for 2 min. The pellets were washed rapidly 3 times with ice-cold buf- 
fer A by repeating centrifugation and were then resuspended in200 pi 
of the same buffer. Bound radioactivity was measured by liquid scin- 
tillation spectrometry by adding a 150 hl aliquot dissolved in scintilla- 
tion liquid. All assays were carried out in triplicate, together with 
triplicate control samples containing 100 gM unlabeled Gpp(NH)p to 
determine nonspecific binding. Either isoproterenol or carbamyi- 
choline was added at a final concentration of 50&M. 
2.3. Adenosine diphosphate (ADP) ribosylation 
Membranes were suspended in 1 ml buffer containing 25 mM Tris, 
pH 7.4, 10 mM nicotinamide adenine dinucleotide (NAD), 1 mM 
ATP, 1 mM EGTA, lOOpM GTP, 2 mM DTT, 5 mM MgClz, 
10 mM th~idine, 20 mM creatine phosphate, and 4O,ug.m1-’ 
creatine phosphokinase. ADP ribosylation was carried out for 
15 min at 30°C by adding cholera toxin (50 fig. ml-i) preactivated for 
10 min at 37°C with 20 mM DTT, or pertussis toxin (25 pg *ml-‘) 
preactivated for 10 min at 30’C with 20 mM Tris. The reaction was 
stopped by adding 25 ml ice-cold 25 mM Tris, pH 7.4, and 5 mM 
MgCll immediately followed by centrifugation at 10000 x g for 
10 min. 13HJGTP binding was then carried out as described. 
3. RESULTS AND DISCUSSION 
Membrane G, protein function was determined by 
measuring ,&-adrenergic agonist modulation of GTP 
binding characteristics. In membranes prepared from 
rat cardiac ventricles, isoproterenol induced over a 
20% increase in 13H]GTP binding capacity, which was 
blocked by propranolol(l0 ,uM), with no significant ef- 
fect on the affinity of GTP (fig.1, table 1). This /?- 
adrenergic agonist-induced increase in [3H]GTP bin- 
ding specifically characterizes G, protein function as it 
is totally abolished by cholera toxin-catalyzed ADP 
ribosylation and is unaffected by pertussis toxin (table 
1). The ,&adrenergic agonist effect of increasing GTP 
binding capacity may be caused by stimulation of the 
dissociation of G, - guanosine diphosphate (GDP), 
which must precede the GTP binding, and by direct 
stimulation of GTP binding [l, 121. 
In contrast to isoproterenol, carbamylcholine did not 
induce any detectable increases in GTP binding capaci- 
ty (table 1). These differences in the ability of the ,8- 
adrenergic and the muscarinic agonists to alter GTP 
binding characteristics in cardiac membranes, may be 
explained by the findings of Gilman et al. (3-51 who 
reported that at low concentrations of Mg2+, the 
tendency of Gi to dissociate appears to be greater than 
that of G,. This characteristic of Gi is an important 
feature in the subunit dissociation model of action of 
this protein as an inhibitory regulator of adenylate 
cyclase activity [3-51. In a previous study, we showed 
that pertussis toxin-blockable, carbamylcholine-in- 
duced increases in GTP binding capacity are mediated 
by the pharmacologically defined Ml muscarinic recep- 
tors, as Mr-selective antagonists had a IOO-fold greater 
ability than Mz-selective antagonists to block carbamyl- 
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Fig. 1. Pertussis toxin-blockable muscarinic agonist inhibition of & 
adrenergic agonist-induced increases in GTP binding capacity. 
Representative Scatchard plots of basal (0) and isoproterenol- 
induced [3H]GTP binding in the absence (0) or presence (a) of 
carbamyicholine to membranes prepared from rat cardiac ventricles. 
(A) Untreated membranes exposed to ~bosylation conditions in the 
absence of pertussis toxin. (B) Membranes pretreated with pertussis 
toxin. Both isoproterenol and carbamylcholine concentrations were 
50 ph4. 
choline effects in rat cerebral cortex [I 11, Moreover, 
the carbamylcholine effect was exclusively detected in 
tissues such as the cerebral cortex and hippocampus, 
which are predominantly populated by Mr receptors, 
whereas cerebellum and cardiac ventricles, which are 
mostly populated by MZ receptors, failed to show car- 
bamylcholine effects on GTP binding to G proteins 
[ 111. The underlying biochemical mechanisms of these 
differences in the carbamylcholine effect are as yet 
unknown and may stem from different coupling 
mechanisms of the various muscarinic receptor sub- 
types. As subtypes of muscarinic receptors differ in 
their primary transducing effect (i.e. induction of 
phosphatidylinositol (PI) turnover vs adenylate cyclase 
inhibition) [ 13- 151, different members of the G protein 
Table 1 
Inhibition of isoproterenol-induced increases in GTP binding by 
carbamylcholine: effects of cholera toxin- and pertussis toxin- 
catalyzed ADP ribosyiation 






None Cholera toxin Pertussis toxin 
10.2 + 0.53 10.7 it 0.6 10.3 4 0.8 
12.9 + 0.77’ 10.4 f 0.58 13.2 f 0.7’ 
10.3 + 0.36 10.2 f 0.47 10.3 f 0.8 
carbamyicholine 10.6 + 0.6 10.3 f 0.8 12.5 + 0.68* 
Rat cardiac ventricle membranes were preactivated with either 
cholera toxin or pertussis toxin to induce ADP ribosylation of G, and 
non-G, proteins, respectively. Untreated membranes were exposed to 
ribosylation conditions in the absence of toxins. The effects of 
isoproterenol(50 pM), carbamylcholine (50 PM), or isoproterenol + 
carbamyicholine on 13H]GTP specific binding were then examined. 
* P < 0.01 for t3H]GTP maximal binding capacity, as compared with 
basal binding capacity 
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family (i.e. Gi, G,, GP) may be involved in the coupling 
of the various muscarinic subtypes to their second 
messenger signaling systems (for review, see [16]). 
Moreover, Florio and Sternweis [17] showed that the 
m~hanism of guanine nucleotide exchange induced by 
hormones and neurotransmitters i more complex than 
previously postulated. Working on the mechanisms of 
muscarinic receptor action on G, in reconstituted 
phospholipid vesicles, these authors found that mus- 
carinic receptors timulate guanine nucleotide exchange 
on Go protein both by increasing the rates of dissocia- 
tion of nucleotides and by altering their relative af- 
finities such that binding of GTP becomes highly 
favored over GDP. 
The fact that carbamylcholine does not induce in- 
creases in GTP bindin capacity to pertussis toxin-, 
sensitive G proteins in cardiac ventricles (table 1) [ 111 
is advantageous for exploring the possibility of a 
muscarinic receptor-coupled effect through Gr on Gs 
protein function proximal to adenylate cyclase. 
Fig. IA shows that carbamylcholine attenuates 
isoproterenol-induced increases in GTP binding capaci- 
ty to G,. This inhibitory effect of carbamylcholine was 
totally abolished by atropine (10pM). This carbamyl- 
choline effect reflects inhibitory influences exerted by a 
pertussis toxin-sensitive G protein on G, as the inhibi- 
tion by ~b~ylcholine of fl-adrenergic-coupled Gs 
function was totally abolished by pretreatment of the 
cardiac membranes with pertussis toxin (table 1, 
fig. 1B). 
Fleming et al. [18] have shown that muscarinic 
agonists inhibit GTP-activated but not Gpp(NH)p- 
activated adenylate cyclase activity, suggesting a role 
for GTP hydrolysis in the mechanism of inhibition of 
adenylate cyclase. Further studies by this group [19] 
indicate that muscarinic receptor stimulation of high 
affinity GTPase activity, which is dependent on func- 
tional pertussis toxin substrate(s), is closely linked to 
the mechanism of muscarinic inhibition of adenylate 
cyclase activity. This muscarinic agonist-stimulated 
GTPase activity may explain our failure to detect 
carbamylcholine-induced increases in GTP binding to 
cardiac membranes, as well as our failure to detect 
isoproterenol-induced increases in GTP binding in the 
presence of c~bamylcholine. Indeed, prelimin~y fin- 
dings from this laboratory indicate that carbamyl- 
choline is able to increase the binding capacity of 
[3H]Gpp(NH)p to cardiac membranes and that iso- 
proterenol-induced increases in t3H]Gpp(NH)p binding 
capacity are not inhibited by carbamylcholine. 
Thus, we show an inhibition of G, protein function 
by a pertussis toxin-sensitive G protein (presumably Gi) 
proximal to adenylate cyclase. We speculate that the& 
subunit complex dissociated upon activation of Gi by 
the cholinergic agonist is responsible for the inactiva- 
tion of GTP bound as protein, probably by favoring 
hydrolysis of the bound GTP. Using an intact mem- 
brane preparation, our present results provide suppor- 
tive evidence for the subunit dissociation model of 
inhibition of adenylate cyclase by Gi, which was ex- 
clusively based on findings in purified and recon- 
stituted systems. 
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